Literature DB >> 11929690

Trypanosoma cruzi: isolation of an immunodominant peptide of TESA (Trypomastigote Excreted-Secreted Antigens) by gene cloning.

Tokiko K Matsumoto1, Paulo C Cotrim, José Franco da Silveira, Anna Maria S Stolf, Eufrosina S Umezawa.   

Abstract

Trypomastigote forms of Trypanosoma cruzi excrete-secrete several molecules, which are immunodominant during the human infection. This complex antigenic mixture termed TESA (Trypomastigote Excreted-Secreted Antigens) presents a 150-160 kDa band that shows excellent specificity and sensitivity in Chagas' disease diagnosis by immunoblotting. Here we describe the isolation and the antigenic characterization of a recombinant peptide (TESA-1) containing a 10 kDa T. cruzi peptide that belongs to the 150-160 kDa TESA fraction. The clone was isolated by screening a T. cruzi genomic expression library with chagasic antibodies reactive to the 150-160 kDa band of TESA immunoblots. After expression, the recombinant peptide TESA-1 was purified and used to immunize rabbits. Anti-TESA-1 immunesera specifically recognized the 150-160 kDa fraction of TESA-blots from eight different T. cruzi strains. The TESA-1 peptide reacted with 82.2% of chagasic patient sera by immunoblotting, showing that it harbors most of the antigenic epitopes that account for the high reactivity of the 150-160 kDa band of TESA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929690     DOI: 10.1016/s0732-8893(01)00348-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

1.  Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods.

Authors:  Juan David Ramírez; Felipe Guhl; Eufrosina Setsu Umezawa; Carlos A Morillo; Fernando Rosas; Jose A Marin-Neto; Silvia Restrepo
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

2.  Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.

Authors:  Mariolga Berrizbeitia; Momar Ndao; José Bubis; Marcelo Gottschalk; Alberto Aché; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 3.  Genetic structure and expression of the surface glycoprotein GP82, the main adhesin of Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  Paulo Roberto Ceridorio Correa; Esteban Mauricio Cordero; Luciana Girotto Gentil; Ethel Bayer-Santos; José Franco da Silveira
Journal:  ScientificWorldJournal       Date:  2013-02-04

4.  Insight into the Exoproteome of the Tissue-Derived Trypomastigote form of Trypanosoma cruzi.

Authors:  Rayner M L Queiroz; Carlos A O Ricart; Mara O Machado; Izabela M D Bastos; Jaime M de Santana; Marcelo V de Sousa; Peter Roepstorff; Sébastien Charneau
Journal:  Front Chem       Date:  2016-11-07       Impact factor: 5.221

Review 5.  A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi.

Authors:  Ángel de la Cruz Pech-Canul; Victor Monteón; Rosa-Lidia Solís-Oviedo
Journal:  J Parasitol Res       Date:  2017-06-05

Review 6.  Trypanosoma Cruzi Genome: Organization, Multi-Gene Families, Transcription, and Biological Implications.

Authors:  Alfonso Herreros-Cabello; Francisco Callejas-Hernández; Núria Gironès; Manuel Fresno
Journal:  Genes (Basel)       Date:  2020-10-14       Impact factor: 4.096

Review 7.  Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids.

Authors:  Edio Maldonado; Sebastian Morales-Pison; Fabiola Urbina; Aldo Solari
Journal:  Vaccines (Basel)       Date:  2022-04-12

8.  In silico, biologically-inspired modelling of genomic variation generation in surface proteins of Trypanosoma cruzi.

Authors:  Francisco J Azuaje; Jose L Ramirez; Jose F Da Silveira
Journal:  Kinetoplastid Biol Dis       Date:  2007-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.